Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Olfactory Receptors: Location and Structure01:03

Olfactory Receptors: Location and Structure

The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Olfaction01:25

Olfaction

The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Physiology of Smell and Olfactory Pathway01:20

Physiology of Smell and Olfactory Pathway

Humans detect odors with the help of specialized cells located in the upper part of the nasal cavity, called olfactory receptor neurons (ORNs). ORNs possess hair-like structures called cilia, which are receptive to sensations from the inhaled air. When an odorant molecule binds to a specific receptor on the cell of the cilia, it leads to a series of events that ultimately cause the ORN to send electrical signals to the olfactory bulb in the brain through the olfactory nerves.
The olfactory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiphospholipid syndrome in the paediatric population: performance of ACR-EULAR classification criteria in a controlled cohort.

Lupus science & medicine·2026
Same author

Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials.

The World Allergy Organization journal·2026
Same author

[Two Sides of the Same Coin: Eosinophilic Granulomatosis with Polyangiitis or Hypereosinophilic Syndrome - A Case Report].

Harefuah·2026
Same author

Antiphospholipid antibodies among hospitalized patients predict mortality and readmission: A real-world 10-years cohort study.

The American journal of medicine·2026
Same author

Eosinophilia and Risk of Thrombosis and Mortality in Hospitalized Patients: A Retrospective Cohort Study.

Life (Basel, Switzerland)·2026
Same author

Massive Honeybee Envenomation: A Case Series of Simultaneous Multiple Casualties.

The Israel Medical Association journal : IMAJ·2026

Related Experiment Video

Updated: Jun 18, 2026

Olfactory Assays for Mouse Models of Neurodegenerative Disease
07:27

Olfactory Assays for Mouse Models of Neurodegenerative Disease

Published on: August 25, 2014

Parkinson's disease, autoimmunity, and olfaction.

Michal Benkler1, Nancy Agmon-Levin, Yehuda Shoenfeld

  • 1Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.

The International Journal of Neuroscience
|November 18, 2009
PubMed
Summary

Parkinson's disease (PD) involves immune system changes, including increased innate and adaptive immune components in patients. Olfactory dysfunction in PD may stem from autoimmune mechanisms, offering new research avenues.

More Related Videos

Simple and Computer-assisted Olfactory Testing for Mice
06:40

Simple and Computer-assisted Olfactory Testing for Mice

Published on: June 15, 2015

Studying the Effects of Inhaled Environmental Pollutants on Olfactory Function in Mice
04:00

Studying the Effects of Inhaled Environmental Pollutants on Olfactory Function in Mice

Published on: September 13, 2024

Related Experiment Videos

Last Updated: Jun 18, 2026

Olfactory Assays for Mouse Models of Neurodegenerative Disease
07:27

Olfactory Assays for Mouse Models of Neurodegenerative Disease

Published on: August 25, 2014

Simple and Computer-assisted Olfactory Testing for Mice
06:40

Simple and Computer-assisted Olfactory Testing for Mice

Published on: June 15, 2015

Studying the Effects of Inhaled Environmental Pollutants on Olfactory Function in Mice
04:00

Studying the Effects of Inhaled Environmental Pollutants on Olfactory Function in Mice

Published on: September 13, 2024

Area of Science:

  • Neuroimmunology
  • Neurodegenerative Diseases

Background:

  • Parkinson's disease (PD) is a progressive neurodegenerative disorder with complex etiopathogenesis involving genetic, environmental, and immunological factors.
  • Nonmotor symptoms, such as olfactory dysfunction, are common in PD and may offer insights into disease mechanisms.

Purpose of the Study:

  • To review immune alterations in Parkinson's disease patients.
  • To explore the potential link between autoimmunity, olfactory dysfunction, and PD pathogenesis.

Main Methods:

  • Review of studies examining immune components in PD patients.
  • Analysis of innate and adaptive immune responses, including complement, cytokines, T cells, and autoantibodies.
  • Comparison with autoimmune diseases exhibiting olfactory dysfunction.

Main Results:

  • Elevated innate immune components (complement, cytokines) in substantia nigra and cerebrospinal fluid (CSF) of PD patients.
  • Increased adaptive immune markers (T cells, autoantibodies like anti-alpha-synuclein and anti-GM1-ganglioside) in blood and CSF.
  • Olfactory dysfunction as a potential early indicator of autoimmune mechanisms in PD.

Conclusions:

  • Immune system dysregulation is a significant feature of Parkinson's disease.
  • Autoimmune processes, potentially linked to olfactory dysfunction, may play a crucial role in PD pathogenesis.
  • Understanding these immune links could pave the way for novel therapeutic strategies to halt PD progression.